ARCHIVES

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 18 | May 4, 2001

Download PDF Visit The Full Archive

Related Articles

14th Cancer Congress Big Success; CICA Satellite Established; US, USSR Renew Cancer Agreement

September 12, 1986

Ethics Advisory Board to Consider Compensation Issue

September 7, 1979

Analysis Finds Exercise Lowers Colon Cancer Risk

February 27, 2009

Patents: Myriad Patents Spectrometry To Assess DNA Polymorphisms

March 5, 1999

NCI Lists Five Comparative Effectiveness Projects For Stimulus Funds

February 6, 2009

“Comprehensive” Tag For Centers A Poor Choice, Word-Conscious NCI Staff, Committee Feel

February 22, 1974